These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15713402)

  • 1. Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.
    Weinstein DS; Liu W; Gu Z; Langevine C; Ngu K; Fadnis L; Combs DW; Sitkoff D; Ahmad S; Zhuang S; Chen X; Wang FL; Loughney DA; Atwal KS; Zahler R; Macor JE; Madsen CS; Murugesan N
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1435-40. PubMed ID: 15713402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment.
    Weinstein DS; Liu W; Ngu K; Langevine C; Combs DW; Zhuang S; Chen C; Madsen CS; Harper TW; Robl JA
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5115-20. PubMed ID: 17656086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase.
    Ngu K; Weinstein DS; Liu W; Langevine C; Combs DW; Zhuang S; Chen X; Madsen CS; Harper TW; Ahmad S; Robl JA
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4141-5. PubMed ID: 21696952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolizine 1-sulfonates as potent inhibitors of 15-lipoxygenase from soybeans.
    Teklu S; Gundersen LL; Larsen T; Malterud KE; Rise F
    Bioorg Med Chem; 2005 May; 13(9):3127-39. PubMed ID: 15809148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Hu H; Liao H; Zhang J; Wu W; Yan J; Yan Y; Zhao Q; Zou Y; Chai X; Yu S; Wu Q
    Bioorg Med Chem Lett; 2010 May; 20(10):3094-7. PubMed ID: 20403694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors.
    Neelamkavil SF; Boyle CD; Chackalamannil S; Greenlee WJ; Zhang L; Terracina G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4563-5. PubMed ID: 19625185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
    Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
    Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin.
    Aubry C; Wilson AJ; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ
    Org Biomol Chem; 2006 Mar; 4(5):787-801. PubMed ID: 16493461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.
    Sawa M; Tateishi H; Mizuno K; Harada H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5963-6. PubMed ID: 15546708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel chromone based sulfonamides as highly potent and selective inhibitors of alkaline phosphatases.
    al-Rashida M; Raza R; Abbas G; Shah MS; Kostakis GE; Lecka J; Sévigny J; Muddassar M; Papatriantafyllopoulou C; Iqbal J
    Eur J Med Chem; 2013 Aug; 66():438-49. PubMed ID: 23831808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitors.
    Chen L; Wang W; Lee KL; Shen MW; Murphy EA; Zhang W; Xu X; Tam S; Nickerson-Nutter C; Goodwin DG; Clark JD; McKew JC
    J Med Chem; 2009 Feb; 52(4):1156-71. PubMed ID: 19178292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of human leukocyte elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamide derivatives.
    Lai Z; Gan X; Wei L; Alliston KR; Yu H; Li YH; Groutas WC
    Arch Biochem Biophys; 2004 Sep; 429(2):191-7. PubMed ID: 15313222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new sulfonamides as lipoxygenase inhibitors.
    Mustafa G; Khan IU; Ashraf M; Afzal I; Shahzad SA; Shafiq M
    Bioorg Med Chem; 2012 Apr; 20(8):2535-9. PubMed ID: 22436389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 15-lipoxygenase-catalysed oxygenation of arachidonic acid by substituted benzoic acids.
    Russell WR; Scobbie L; Duthie GG; Chesson A
    Bioorg Med Chem; 2008 Apr; 16(8):4589-93. PubMed ID: 18314336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted coumarins as potent 5-lipoxygenase inhibitors.
    Grimm EL; Brideau C; Chauret N; Chan CC; Delorme D; Ducharme Y; Ethier D; Falgueyret JP; Friesen RW; Guay J; Hamel P; Riendeau D; Soucy-Breau C; Tagari P; Girard Y
    Bioorg Med Chem Lett; 2006 May; 16(9):2528-31. PubMed ID: 16464579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach.
    Charlier C; Hénichart JP; Durant F; Wouters J
    J Med Chem; 2006 Jan; 49(1):186-95. PubMed ID: 16392803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-substituted purines as inhibitors of 15-lipoxygenase; a structure-activity study.
    Bråthe A; Gundersen LL; Malterud KE; Rise F
    Arch Pharm (Weinheim); 2005 Apr; 338(4):159-66. PubMed ID: 15864785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors.
    Sadeghian H; Seyedi SM; Saberi MR; Arghiani Z; Riazi M
    Bioorg Med Chem; 2008 Jan; 16(2):890-901. PubMed ID: 17998164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.